Last reviewed · How we verify

NCT07241455

Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care Patients

Completed Last updated 11 February 2026
What this trial tests

trial in Pediatric Critical Illness; Physical Function Assessment; Functional Status; Rehabilitation in 50 participants. Completed in 10 December 2025.

Timeline
1 September 2025
Primary endpoint
1 December 2025
10 December 2025

Quick facts

Lead sponsorIstanbul Medeniyet University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 September 2025
Primary completion1 December 2025
Estimated completion10 December 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul Medeniyet University

Who can join

Adults 2 to 18, any sex, with Pediatric Critical Illness; Physical Function Assessment; Functional Status; Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-center, prospective observational study aims to translate, culturally adapt, and evaluate the validity and reliability of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx) in Turkish pediatric intensive care settings (cCPAx-TR). We will assess content validity with an expert panel, feasibility in a pilot run, test-retest reliability, internal consistency, and criterion validity against established clinical scores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07241455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing